Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Pliant Therapeutics (PLRX) over the last 6 years, with Q3 2025 value amounting to 0.69%.

  • Pliant Therapeutics' Return on Capital Employed fell 1600.0% to 0.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.54% for FY2024, which is 800.0% down from last year.
  • As of Q3 2025, Pliant Therapeutics' Return on Capital Employed stood at 0.69%, which was down 1600.0% from 0.73% recorded in Q2 2025.
  • Over the past 5 years, Pliant Therapeutics' Return on Capital Employed peaked at 0.27% during Q1 2021, and registered a low of 0.73% during Q2 2025.
  • Its 5-year average for Return on Capital Employed is 0.46%, with a median of 0.44% in 2024.
  • In the last 5 years, Pliant Therapeutics' Return on Capital Employed tumbled by -3300bps in 2022 and then soared by 3700bps in 2023.
  • Pliant Therapeutics' Return on Capital Employed (Quarter) stood at 0.46% in 2021, then grew by 19bps to 0.37% in 2022, then increased by 1bps to 0.37% in 2023, then crashed by -59bps to 0.59% in 2024, then decreased by -17bps to 0.69% in 2025.
  • Its last three reported values are 0.69% in Q3 2025, 0.73% for Q2 2025, and 0.69% during Q1 2025.